Akebia Therapeutics
AKBA
#6961
Rank
โ‚ฌ0.38 B
Marketcap
1,81ย โ‚ฌ
Share price
4.02%
Change (1 day)
117.95%
Change (1 year)

Earnings for Akebia Therapeutics (AKBA)

Earnings in 2024 (TTM): -โ‚ฌ37.79 Million

According to Akebia Therapeutics's latest financial reports the company's current earnings are โ‚ฌ0.17 Billion. In 2023 the company made an earning of -โ‚ฌ48.46 Million, an increase over its 2022 earnings that were of -โ‚ฌ88.3 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Akebia Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ37.79 Million-22.01%
2023 -โ‚ฌ48.46 Million-45.12%
2022 -โ‚ฌ88.3 Million-66.55%
2021 -โ‚ฌ0.27 Billion-26.24%
2020 -โ‚ฌ0.36 Billion33.94%
2019 -โ‚ฌ0.27 Billion66.52%
2018 -โ‚ฌ0.17 Billion123.53%
2017 -โ‚ฌ71.78 Million-43.34%
2016 -โ‚ฌ0.13 Billion123.58%
2015 -โ‚ฌ56.67 Million63.95%
2014 -โ‚ฌ34.56 Million181.24%
2013 -โ‚ฌ12.29 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚ฌ4.36 B-11,669.66%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ11.88 B-31,582.12%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ17.16 B-45,584.89%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.17 Billion 338.06%๐Ÿ‡บ๐Ÿ‡ธ USA